To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
Sponsored by Robert E. Latta RRepublican, introduced . Policy area, as Congress files it: Health.
Status is read from the official actions by their Library of Congress codes: Became Public Law (36000) or a law number on the bill reads "Became law"; Vetoed (31000) reads "Vetoed"; Presented to President (28000) reads "Sent to the President"; passed or agreed to in the House (8000) and in the Senate (17000) reads "Passed both chambers"; one of them alone reads "Passed the House" or "Passed the Senate" ("Agreed to" for a resolution); reported to the House (5000) or the Senate (14000) reads "Reported by committee"; anything else reads "Introduced".
Source: Congress.gov data service (Library of Congress). Text versions: our copies of govinfo.gov’s files. Our copy was saved October 16, 2026.
Cosponsors
1 cosponsor.
| Member | Joined |
|---|---|
| Greg Landsman DDemocratOriginal cosponsor |
Text
| Version | Date | Our copy |
|---|---|---|
| Introduced in House | Not checked yetThe official file |
Actions
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Introduced in House
Committees
- Energy and Commerce Committee (House)Referred To, July 20, 2026
Hearings
We hold hearing records only for bills that became law.
Who lobbied on this bill
Not checked yetNo lobbying report we hold names H.R. 9774.